We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MARPS:NASDAQMarine Petroleum Trust Analysis

Data as of 2026-04-16 - not real-time

$5.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Marine Petroleum Trust trades around $5, comfortably above the computed support of $4.64 but well beneath the resistance near $5.96. The 20‑day SMA ($5.31) sits above the 50‑day ($5.06) and 200‑day ($4.67) averages, signaling a bullish trend, yet the MACD histogram is negative and the MACD signal is labeled bearish, suggesting short‑term downside pressure. RSI at 45.6 points to a neutral momentum with a slight tilt toward oversold conditions. Volume is on a decreasing trajectory, and the 30‑day volatility exceeds 80%, highlighting a potentially choppy price environment. Despite market turbulence, the company boasts a strong balance sheet with over $1 million in cash, zero debt, and a striking ROE of roughly 78%, while trading at a PE of 13.9 versus an industry average of 21.5, indicating relative undervaluation. The dividend yield of 6.6% and a payout ratio of 85% are attractive, though the high price‑to‑book multiple (~9.9) reflects the low book value typical of royalty trusts. Beta is negative in the computed set (‑0.47) and modestly positive in the quote (0.354), implying limited correlation with broader market moves. Overall, the stock presents a blend of value appeal through earnings and dividend strength, tempered by high volatility and thin liquidity.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram and signal
  • Decreasing volume trend
  • Proximity to technical support level

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Bullish SMA alignment (20 > 50 > 200)
  • PE well below industry average
  • Strong cash position and zero debt

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • High, sustainable dividend yield
  • Robust ROE and ROA metrics
  • Limited market correlation (negative/low beta)

Key Metrics & Analysis

Financial Health

Revenue Growth61.70%
Profit Margin68.95%
P/E Ratio13.9
ROE77.72%
ROA48.57%
P/B Ratio9.9
Industry P/E21.5

Technical Analysis

TrendBullish
RSI45.6
Support$4.64
Resistance$5.96
MA 20$5.31
MA 50$5.06
MA 200$4.67
MACDBearish
VolumeDecreasing
Fear & Greed Index88.98

Valuation

GradeUndervalued
TypeValue
Dividend Yield6.60%

Risk Assessment

Beta-0.47
Volatility80.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.